Song Hong Fang sold CGON

January 29, 2024 · Form 4 insider transaction

Song Hong Fang sold 6,262,967 shares of CG Oncology, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
6,262,967
Price
N/A
Total value
N/A
RoleDirector
SecuritySeries C Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateJanuary 29, 2024
Filing dateJanuary 31, 2024
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.; Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.; Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

View the original Form 4 on SEC EDGAR